Enzo Biochem, Inc. (NYSE:ENZ – Get Free Report) declared a dividend on Tuesday, October 29th, NASDAQ reports. Investors of record on Friday, November 15th will be paid a dividend of 0.10 per share by the medical research company on Monday, December 2nd. The ex-dividend date of this dividend is Friday, November 15th.
Enzo Biochem Trading Up 2.7 %
Shares of NYSE:ENZ traded up $0.03 on Wednesday, hitting $1.16. The company’s stock had a trading volume of 331,081 shares, compared to its average volume of 95,885. Enzo Biochem has a 12 month low of $0.99 and a 12 month high of $1.50. The stock’s 50-day moving average is $1.13 and its two-hundred day moving average is $1.11.
Analyst Upgrades and Downgrades
Separately, StockNews.com assumed coverage on Enzo Biochem in a report on Wednesday. They issued a “hold” rating for the company.
About Enzo Biochem
Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.
Featured Articles
- Five stocks we like better than Enzo Biochem
- Options Trading – Understanding Strike Price
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What is a Stock Market Index and How Do You Use Them?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
